DMA110 - Pharmaceutical & Technology Clinical Management

DMA110: Demystifying Market Access in the South African Healthcare Environment

Moderated by Mark Brand

Course Summary

Medical device registration e.g. FDA and CE, which are critical quality, safety and efficacy indicators, are merely authorizations to sell a technology, and the absolute minimum requirement for market access, but are not a guarantee for adoption and/or reimbursement; policy makers demand more!

Introducing new technologies to the South Africa Healthcare market is a daunting task, given the potential roadblocks presented by payers and policy makers to manage utilization and health care costs. Although it has a market access focus, this workshop is not exclusively for market access personnel, and every level of business decision-maker will benefit by attending.

Why should you attend?

If product and procedure reimbursement is a key factor for successful market access.
understand processes that could reduce time bringing products to market.
If you are looking at a strategic approach to market access to optimise efficiencies.
If you need to successfully communicate a value proposition for your technology.
If you want to be part of the solution, not the problem, of managing the business of health care cost effectively.

Who should attend?

Any medical device company representative who is involved in introducing new health technologies to the market, including:

Chief Executives,
Business Unit Managers,
Product Managers,
Marketing Managers and
Market Access Managers.

Terms and Conditions

Programme

HTA102 Guest Lecture - 20 Aug
Introduction to Health Technology Assessment; an approach to Devices and Technology
Study Unit 1: Navigating the South African Healthcare Environment
- Structure and relationship of stakeholders within the industry (public and private)
- Unpack the role and responsibilities of stakeholders in the funding industry
- Navigating market access processes
Study Unit 2: Health Technology Management
- Upstream (pre-launch) activities important for successful market access
- Principles of health technology assessment (HTA)
- Downstream (post-launch) activities for sustainable market access
Study Unit 3: Developing a Market Access Strategy
- The value proposition
- Stakeholder analyses
- Aligning business and market access strategies
- Developing the dossier etc